Effects of low-dose infliximab on spinal inflammation on magnetic resonance imaging in ankylosing spondylitis.
Rudwaleit
Martin
M
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D018501:Antirheumatic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D018450:Disease Progression; D006304:Health Status; D006801:Humans; D007249:Inflammation / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D000069285:Infliximab; D008279:Magnetic Resonance Imaging; D020127:Recovery of Function; D012720:Severity of Illness Index; D013131:Spine / Q000473:pathology*; D013167:Spondylitis, Ankylosing / Q000188:drug therapy* / Q000473:pathology / Q000503:physiopathology; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D018501:Antirheumatic Agents; D000069285:Infliximab